Demand for nebulisers, inhalers, and respiratory medications for children in Delhi has skyrocketed by up to 60% during winter, as air pollution worsens seasonal respiratory issues. Chemists across South, East, North, and Central Delhi reported sharp sales spikes from November to January, when smog peaks.
Child Respiratory Distress Rises
Nearly one-third of nebuliser sales targeted children, signaling heightened vulnerability among youth to cough, wheezing, breathlessness, and chest tightness—symptoms intensifying in early mornings and evenings. Popular drugs like Asthalin, Levolin, Budecort, Seroflo, Duolin Respules, and Budecort solutions saw north Delhi inhaler sales jump 40%, with central/south Delhi nebuliser demand up 50-60%.
Survey Highlights Supply Strains
The findings stem from ‘Warrior Moms’ annual survey, partnering with Delhi pharmacists, expanded this year for broader insights. Pharmacies faced stock shortages of high-demand respules during peak pollution, underscoring urgent supply chain gaps.
Urgent Recommendations
The report brands these trends a “public health warning,” urging pre-stocking of aids, better logistics, and school-based awareness to shield children from winter smog’s toll.
